N-glycan-defective breast cancer cells induce a phenotypic switch in polarization of bone marrow-derived macrophages Abstract Purpose: To investigate the e ect of N-glycan-defective mammary adenocarcinoma cells on the polarization of macrophages.
Carbohydrates are attached to proteins in two major linkages: N-glycans and O-glycans. Carbohydrate chains in mature N-glycans include the typical high-mannose, hybrid and complex forms. N-acetylglucosaminyltransferase V (Mgat5 or GnT-V) plays an important regulatory role in the synthesis of complex N-glycans and this process is highly conserved between yeast and mammals [1] . Mgat5 and its glycan products, beta-1,6-GlcNAc-branched N-glycans, are tumor-associated glycoproteins that are commonly increased in malignancies and their level of expression has been found to correlate with disease progression [2] [3] [4] . Furthermore, many studies have demonstrated the association between increased leukoagglutinin (L-PHA) binding and increased tumor cell invasiveness. Likewise, cancers of breast, colon and melanomas show increased levels of beta-1,6-GlcNAc-branched N-glycan measured by L-PHA immunohistochemistry [2, 5] , as L-PHA has been shown to bind speci cally to this structure [2] . As reported [5] , L-PHA reactivity is also increased in atypical hyperplasia and carcinomas of breast in comparison with normal and benign lesions. Beta-1, 6-branched oligosaccharides are increased in lymph node metastases and are predictors of poor prognosis of breast carcinoma.
In previously studies, blocking expression of Mgat5-modi ed glycans in murine mammary adenocarcinoma MA782 cells using short hairpin RNA (shRNA) has been shown to prevent Mgat5-suppressed tumor progression both in vi o and in vitro and to activate CD4+ T cells and macrophages [6] , but the incipient mechanism for this phenomenon is still ill-de ned. Tumor cells use multiple mechanisms to invade extracellular matrix and metastasize to distant organs. e interaction between the tumor cells and stromal cells in the tumor microenvironment plays an important role in tumor growth and metastasis and macrophages are prominent stromal cells in this interaction. Macrophages secrete a variety of growth factors, cytokines, chemokines and enzymes that regulate tumor growth, angiogenesis, invasion and metastasis [7] . Macrophages are highly versatile, as local environmental factors shape their phenotypic and functional properties [8] . Operationally, two distinct activation states have been de ned for macrophages: the M1 (or classically activated) and M2 (or alternatively activated) macrophages, each associated with speci c phenotypes and functions [8] [9] [10] . M1 macrophages typically produce copious amounts of proin ammatory cytokines (tumor necrosis factor alpha, interleukin-12) and generate reactive oxygen species. M1 macrophages participate as inducers and e ectors in T helper-1 immunity. M2 macrophages secrete high levels of anti-in ammatory cytokines (IL-10) and are characterized by increased arginase-1 (Arg-1) activity and surface expression of macrophage mannose receptor (MMR, CD206) and dectin-1. Functionally, M2 macrophages are considered to tune in ammatory responses and promote tissue repair [11, 12] .
In this study, beta-1,6-GlcNAc-branched N-glycandefective MA782 cells were prepared by Swainsonine (SW) treatment, and the e ect of beta-1,6-GlcNAc-branched Nglycan on the polarization of macrophages was investigated.
Materials and Methods
Macrophage isolation and culture.
Bone marrow-derived macrophages (BMDMs) were obtained using the technique described previously [13] : DMEM (Invitrogen Life Technologies, Carlsbad, CA), containing 2 mM glutamine, 100 U/mL penicillin, 100 μg/mL streptomycin, 0.37% (wt/vol) NaHCO3, 10% (vol/vol) heat-inactivated FBS, and 10% (vol/vol) L929 cell-conditioned medium, as a source of M-CSF, was used for the isolation, culture, and stimulation of the macrophages. Bone marrow cells were aseptically ushed from the dissected pelvises, femurs and tibias of BALB/c mice with a jet of complete medium directed through a 25-gauge needle. e bone marrow cells were adjusted to a density of ~3 x 10 5 cells/mL of medium and distributed in 2 mL aliquots into 22 mm diameter wells of 12-well tissue culture plates or 13 mL aliquots into 100 mm diameter culture dishes. e cells were maintained at 37ºC under a 10% (vol/ vol) CO 2 atmosphere for 5 d and therea er the medium was changed on alternate days until the cells were used between days 5 and 7.
Swainsonine treatment MA782 cells derived from mouse mammary adenocarcinoma 14 were grown in DMEM that was supplemented with 10% FBS. For SW treatment, MA782 cells were diluted to 1×10 6 cells/ mL, and seeded into 6-well plate at 2 mL per well. SW (Sigma, St.Louis, MO, USA) was added at 1 μg/mL or 5 μg/mL to the medium with MA782 cells. A er 24 h incubation, MA782 cells were harvested and washed several times with fresh medium.
Transfection e cDNA of Mgat5 was cloned into eukaryotic expression vector pcDNA3.1A to yield plasmid pcDNA3.1-Mgat5 as described previously [6] . Plasmids were puri ed using endotoxinfree DNA extraction kit (QIAGEN, Valencia, CA). A total of 5×10 5 cells/mL were plated in 60 mm plates at a density ap-propriate to achieve 60% con uency 24 h before transfection. Cells were transfected with 4 μg of each plasmid using Lipofectin2000 (Invitrogen Life Technologies). Cells were harvested 72 h post transfection and suspended in PBS.
A er being treated with SW for 24 h, MA782 cells were collected. FITC-conjugated leukoagglutinin (L-PHA, Vector Laboratories, Peterborough, UK) was added to a nal concentration of 2.5 μg/mL in PBS, and cells were incubated for 30 min at 4ºC . e cells were collected by centrifugation and then suspended in 1 mL PBS-BSA for ow cytometry (FCM) analysis.
Cell proliferation assay.
3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT; Sigma, St.Louis, MO, USA) proliferation assay was used to determine the e ects of SW on MA782 cell growth. e cells were resuspended in fresh medium, diluted to 1×10 5 cells/mL, and seeded into four 96-well plates at 100 μL per well. Cells were treated with SW at doses of 1, 3 or 5μg/ mL, and grown for up to 4 days. One plate was used for MTT assay each day for a total of 4 days. Twenty microliters of MTT (5 mg/mL) was added to each well, and the cells were incubated at 37ºC for another 4 h. e culture medium was then replaced with 150 μL dimethyl sulfoxide (Sigma). A er shaking for 10 min, the plate was read for the absorbance at 490 nm on a plate reader. e proliferation rate was determined as follow: absorbance of treated group/absorbance of untreated group.
BMDMs were stained with the following monoclonal antibodies diluted in 1% FBS in PBS: PE anti-F4/80 (eBioscience, San Diego, CA), PE anti-CD16/32 (BD Biosciences, San Diego, CA), PE anti-CD206 (BD Biosciences), PE anti-Dectin-1 (eBioscience). e surface molecule F4/80, CD16/32, CD206 and Dectin-1 were analysed according to the protocols of the manufacturer in a Beckman Coulter EPICS ALTRA II ow cytometer.
derived macrophages
Bone marrow-derived macrophages and SW-treated or -untreated MA782 cells were co-cultured in 6-well plate in a ratio of 1:10 at 37ºC . ere were 2×10 5 BMDMs and 2×10 6 Nglycan-defective MA782 cells in each well of a 6-well plate with a total culture medium volume of 2 mL. A er 48 h incubation, the supernatants of each well were collected separately via centrifugation for the ELISA assay and the BMDMs were collected for the phenotypic analysis.
A er co-cultured for 48 h, the medium of each well were collected separately with centrifugation, and IL-10 and TNFalpha contents were then determined with ELISA kit (eBioscience) as described by the manufacturer.
uantitative RTTotal RNA was extracted from the cell lysates using TRIZOL (Gibco-Invitrogen). RNA was measured by the real-time reverse transcription polymerase chain reaction using the uantiTect TM SYBR Green PCR Handbook Kit (QIAGEN). e samples were heated to 95ºC for 5 min, followed by 30 cycles of 95ºC for 10 s, 59ºC for 15 s, and 72ºC for 20 s. e oligonucleotide primers used were as follows: iNOS forward: 5'-CTG CAGCACTTGGATCAGGAACCTG -3' , reverse: 5'-GGA GTAGCCTGTGTGCACCTGGAA-3'; Arg-1 forward: 5'-CAGAAGAATGGAAGAGTCAG-3' , reverse: 5'-CAGATAT GCAGGGAGTCACC-3'; GAPDH forward: 5'-ACCACA GTCCATGCCATCAC-3' , reverse: 5'-TCCACCACCCTG TTGCTGTA-3' . Primers were synthesized by Shanghai Sangon Biological Engineering Technology & Services Co., Ltd.
e relative expression quantity of target gene in each sample was normalized by comparing with that of GAPDH.
Measurement of nitrite production using the Griess reaction
Nitrite in culture supernatants was measured by adding 100 μL of Griess reagent (1% sulfanilamide and 0.1% N- [1-naphthyl] ethylenediamine dihydrochloride in 5% phosphoric acid) to 100 μL samples of medium. All measurements were performed in triplicate. e concentration of NO2 -was determined using a standard curve generated with NaNO 2.
Cells were lysed in 0.1% Triton X-100. Tris-HCl was added to yield nal concentrations of 12.5 mM and MnCl 2 added to nal concentrations of 1 mM. Arginase was activated by heating for 10 minutes at 56°C, and L-arginine substrate was added to nal concentrations of 250 mM . Reactions were incubated at 37°C for 30 minutes and 4 . A er addition of α-isonitrosopropiophenone and heating for 30 minutes at 95°C, urea production was measured by absorbance at 540 nm and normalized to total protein content. All measurements were performed in triplicate.
Data were expressed as the mean ± standard error of the mean (SEM) of at least three independent experiments each performed in triplicate. All statistical analyses were performed in the SPSS 11.0 statistical so ware package. Experimental data were analyzed by ANOVA, with the Student-Newman-Keuls method for multiple comparisons among means. Values of p < 0.05 were considered statistically signi cant.
Results
without cytotoxicity e plant lectin leukoagglutinin (L-PHA) binds speci cally to mature Mgat5 products [15] and, therefore, has been used as a probe for Mgat5-modi ed glycans. Inhibition of Mgat5-modi ed N-glycan product expression by SW was examined by L-PHA binding assay. e results showed that L-PHA binding to Mgat5-modi ed glycans on MA782 cells was signi cantly decreased in SW-treated cells compared with parental cells in a dose-dependent manner Fig. 1A , 1B, *p<0.05). Furthermore, the N-glycan were still defective on MA782 cells 48 h a er SW treatment as measured by L-PHA binding assay (Fig. 1C , *p<0.05). Cell proliferation assay showed that SW had no inuence on the MA782 cell growth at either 1 μg/mL or 5 μg/ mL, in comparison with parental cells (Fig. 1D) . ese data indicate that SW signi cantly inhibits N-glycan biosynthesis in MA782 cells in vitro for at least 48 h, without cytotoxicity.
BMDMs
A er been cultured in vitro for 7 consecutive days, bone marrow-derived macrophages were harvested for phenotypic analysis. e ow cytometry data showed that more than 90% of the BMDMs expressed the macrophage-speci c marker, F4/ 80 ( Fig. 2A) . To investigate the e ect of N-glycan-defective MA782 cells on the BMDMs, the BMDMs were co-cultured with N-glycan-defective MA782 cells for 48 h, then the expression of iNOS and Arg-1 in macrophages were detected using FQRT-PCR and enzyme activity tests, as described above. e results of FQRT-PCR analysis showed that the expression of iNOS mRNA in macrophages co-cultured with N-glycan-defective MA782 cells was signi cantly increased in comparison with macrophages co-cultured with parental MA782 cells, whereas the expression of Arg-1 was signi cantly decreased (Fig. 2B, *p<0.05 ). e results of the Griess reaction showed that there was more accumulated nitrite in the culture medium of macrophages co-cultured with N-glycan-defective MA782 cells than in the medium of macrophages co-cultured with parental MA782 cells (Fig. 2C, *p<0 .05). Moreover, higher arginase activity was observed in macrophages cocultured with parental MA782 cells detected by arginase assay as described (Fig. 2C , *p<0.05). ese data indicate that Nglycan-defective MA782 cells induce iNOS expression in BMDMs, but not arg-1 expression. It may be that the Nglycan-defective MA782 cells induce BMDMs to di erentiate mainly into proin ammatory M1 macrophages.
BMDMs e surface molecule expression is di erent for M1 and M2 macrophages. To evaluate the e ect of N-glycan-defective MA782 cells on the surface molecules expressed in the BMDMs, the expression of CD16/32, CD206 and dectin-1 in the BMDMs co-cultured with N-glycan-defective MA782 cells was analyzed by ow cytometry. e results of FCM showed that BMDMs co-cultured with N-glycan-defective MA782 cell expressed more CD16/32 with less CD206 and dectin-1 expression than BMDMs co-cultured with MA782 cells (Fig.  3A, 3B , 3C, *p<0.05). Taken together, phenotypic di erences were apparent between the macrophages co-cultured with Nglycan-defective MA782 cells and those co-cultured with parental MA782 cells, and BMDMs co-cultured with N-glycandefective MA782 cell were probably polarized to the M1 phenotype.
α expression in BMDMs
To further verify the ability of N-glycan-defective MA782 cells to induce a phenotypic switch in BMDM polarization, the cytokines secreted into the culture medium a er co-cultured for 48 h were detected by ELISA. e results of ELISA imply that macrophages co-cultured with N-glycan-defective MA782 cell secreted more TNF-alpha and less IL-10 into supernatant than macrophages co-cultured with parental MA782 cells (Fig.  4A, 4B , *p<0.05). Taken together, these data support the hypothesis that N-glycan-defective MA782 cells induce BMDMs to di erentiate into proin ammatory M1 macrophages.
BMDMs
Although SW can inhibit N-glycan synthesis, this chemical is also well-known for other functions. To con rm that the polarization of BMDMs is caused by the e ect of N-glycan on MA782 cells, but not other factors, MA782 cells were transfected with the plasmid pcDNA3.1-Mgat5 and the vector plasmid pcDNA3.1A. e enhanced expression of N-glycan on MA782 cells 72 h a er transfection with pcDNA3.1-Mgat5 was observed as measured by L-PHA binding assay (Fig. 5A , *p<0.05). N-glycan-enhanced MA782 cells were co-cultured with BMDMs for 48 h, then the expression of iNOS and Arg-1 in macrophages was detected. e results of FQRT-PCR showed that the expression of Arg-1 mRNA in macrophages co-cultured with N-glycan-enhanced MA782 cells was signicantly increased in comparison with those co-cultured with parental MA782 cells or MA782 cells transfected with vector plasmid, whereas the expression of iNOS was signi cantly decreased (Fig. 5B, *p<0.05) . ese data indicate that the overexpression of Mgat5 in MA782 cells, which leads to the enhanced N-glycan expressed on the cells surface, could induced Arg-1 expression in BMDMs.
Discussion
In a previous study, Mgat5 speci c-short hairpin RNA (shRNA) not only blocks expression of Mgat5 and Mgat5-modi ed glycan products, but also inhibits MA782 cell growth in vitro [6] . To avoid the in uence of the viability of MA782 cells on the results of this study, when co-cultured with BMDMs, Mgat5 speci c shRNA was replaced by SW, an Nglycan inhibitor that inhibits Golgi alpha-mannosidase II and ultimately causes the inhibition of N-linked beta-1,6-oligosaccharide expression upstream of the action of Mgat5 [16] . e L-PHA binding assay showed that L-PHA binding to Mgat5-modi ed glycans on MA782 cells was signi cantly decreased in SW-treated cells in comparison with parental cells and that this decrease was dose-dependent (Fig. 1A, 1B , *p<0.05). Furthermore, the MTT assay showed that SW had no in uence on the MA782 cell growth (Fig. 1D) . Jun Hamaguchi et al. also reported that SW, at the concentration of 5 μg/ mL, showed no cytotoxicity on murine colorectal cancer cells [17] . ese data indicated that SW could e ectively inhibit N- 
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Macrophages are a major component of in ammatory inltrate of tumors [18, 19] . Tumor-associated macrophages (TAMs) have complex dual functions in terms of their antitumor or pro-tumor e ects. is functional complexity is related to the heterogeneity of macrophage population, which holds a continuum of diverse functional states. At one end of the continuum are the classically-activated M1 macrophages that produce e ector molecules, such as reactive oxygen intermediates, reactive nitrogen intermediates and TNF-alpha, to limit tumor growth. Ohri et al. recently reported that the M1 macrophage density in the tumor islets is positively associated with extended survival of NSCLC patients [20] . At the other end are the alternatively-activated M2 macrophages that promote tumor growth and metastasis by secretion of matrixdegrading enzymes, angiogenic factors and immunosuppressive cytokines/chemokines [10] . e balance of these macrophage forms determines the anti-or pro-tumor e ects of the macrophage population [18] . In this study, parental MA782 cellstimulated BMDMs up-regulate the expression of both M1 macrophage markers (iNOS, TNF-alpha) and M2 macrophage markers (arg-1, CD206, dectin-1, IL-10) (Fig. 2, Fig. 3, Fig. 4 ), in comparison with BMDMs cultured alone, although for most markers, these di erences were not statistically signicant. ese data indicate that MA782 cells induce polarization of BMDMs to both M1 macrophages and M2 macrophages. Interestingly, this balance could be switched when BMDMs co-cultured with N-glycan-defective MA782 cells: BMDMs stimulated by N-glycan-defective MA782 cells expressed more M1 macrophage markers, such as iNOS, CD16/32 and TNFalpha (Fig. 2, Fig. 3, Fig. 4) , and less M2 macrophages markers, such as arg-1, CD206, dectin-1 and IL-10 ( Fig. 2, Fig. 3, Fig.  4 ), than those co-cultured with parental MA782 cells. en, to further con rm the role of N-glycan in inducing a phenotypic switch in BMDMs polarization, the N-glycan expression on MA782 cells was upregulated following transfection with the plasmid pcDNA3.1-Mgat5, which encoded the cDNA of mouse Mgat5 (Fig. 5A) . Interestingly, BMDMs co-cultured with N-glycan-enhanced MA782 cells expressed more Arg-1 and less iNOS than those co-cultured with MA782 cells transfected with the vector plasmid (Fig. 5B, *p<0.05) . ese ndings suggest that the polarization of BMDMs co-cultured with MA782 cells was closely related to the changes in N-glycan on the MA782 cells. All of these data indicate that N-glycandefective MA728 cell induce a phenotypic switch in BMDM polarization, where BMDMs di erentiated mainly into proinammatory M1 macrophages.
Several lines of evidence indicate that the in ammatory cells and cytokines found in tumors are more likely to contribute to tumor growth, progression and immunosuppression than they are to mount an e ective host antitumor response 19 . Macrophages play an important role in this scenario as these cells produce large quantities of pro-and anti-in ammatory cytokines, which can promote cancer dissemination and metastasis. Blot et al. showed that the deleterious role of macrophages in cancer progression is due to the cooperation of monocytes with cancer cells [21] , and the modi cations of macrophages functions in tumours could be explained by a switch of M1 macrophages to M2 macrophages, which have protumoral properties [22, 23] . Our data indicate that Nglycan-defective breast cancer cells can induce BMDMs to differentiate into M1 macrophages, which suggests that downregulated the expression of N-glycan on breast cancer cells could enhance the antitumor e ects of TAMs. Further, it has been accepted that fully activated macrophages have the potential to inhibit tumour development. TAMs that express an M1 phenotype are capable of killing tumour cells mainly by secreting in ammatory cytokines such as Tumour Necrosis Factor alpha [24] . Bolpetti et al. found IL-10 can facilitate tumor growth and decrease anti-tumor antigen T cell response [25] . Our data showed that N-glycan-defective MA782 cells can induce BMDMs to express more TNF alpha and less IL-10 ( Fig. 4A, 4B ), which should be bene cial to the antitumor immune response.
Knockdown of Mgat5-inhibited MA782 cell growth in vi o has been reported following activation of CD4+T cells and macrophages. is phenomenon might be due to the reduction of beta-1,6-GlcNAc-branched N-glycan on tumor cells that results from the knockdown of Mgat5 and/or the alteration or exposure of some Ag epitopes, which in turn activates APC in subcutaneous tissue and eventually up-regulates CD4+T cell proliferation and TNF-alpha and IFN-gamma production [6] . In the present study, N-glycan-defective MA782 cells have been found to induce the di erentiation of BMDMs to proin ammatory M1 macrophages, which could produce e ector molecules to limit tumor growth. us, Nglycandefective tumor cells may induce the di erentiation of tumor-associated macrophages into M1 macrophages, which have powerful antigen present capability, therefore enhance 1 immunity response, and eventually inhibit tumor cells growth in vi o.
In conclusion, the beta-1,6-GlcNAc-branched N-glycan on MA782 cells has been found to be critical in tumor development and host immune response. 
